Gilead Sciences, Inc. GILD Prévisions boursières
Prédiction de prix et analyse propulsées par l'IA pour Gilead Sciences, Inc. · Mise à jour Avr 16, 2026
Prévision IA à 90 jours
ACHETER
7 jours
30 jours
90 jours
Confiance de l'IA: 27% Corrélation de Spearman
avril 16, 2026
Voir l'objectif de prix exact de GILD
Créez un compte gratuit pour débloquer les prédictions IA pour plus de 4 000 actions
Inscrivez-vous gratuitement avec Google✓ Compte gratuit · ✓ Essai de 30 jours · ✓ Annuler à tout moment
Graphique des prix
Chargement du graphique...
Statistiques clés
Capitalisation boursière
$173.45B
Ratio P/E
20,4x
Ratio P/B
7,64x
Rend. dividende
2,31%
BPA
$2,48
ROE
20,5%
Marge nette
36,5%
Chiffre d'affaires
$29B
Ratio de liquidité générale
1,55x
A propos de Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) opère dans le secteur Life Sciences, spécifiquement dans le secteur Biological Products, (No Diagnostic Substances). .
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. …
Dernières actualités
- Gilead Sciences, Inc. (GILD) is a trending stock: Facts to know before betting on it
- Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration
- PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
- Inscrivez-vous gratuitement pour lire les 10 articles →
Biological Products, (No Diagnostic Substances) Entreprises comparables
| Entreprise | Ticker | Signal IA | Capitalisation boursière | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $194M | -x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $420K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.67B | -x |
| Alpha Cognition Inc. | ACOG | ██% | $145M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.55B | 17,4x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.17B | -x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $164M | 1425,1x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $5M | -x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $281M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $47M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $544M | -x |
| Alvotech | ALVO | ██% | $1.13B | -x |
| Amgen Inc | AMGN | ██% | $188.25B | 24,4x |
| Apogee Therapeutics, Inc. | APGE | ██% | $6.19B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $51.26B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $417M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $296M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $43M | 1,3x |
| Atyr Pharma Inc | ATYR | ██% | $81M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $449M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $428M | -x |
| Anavex Life Sciences … | AVXL | ██% | $315M | -x |
| Bioatla, Inc. | BCAB | ██% | $8M | -x |
| Biocardia, Inc. | BCDA | ██% | $13M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $9M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.39B | 9,1x |
| Black Diamond Therapeutics, … | BDTX | ██% | $167M | 7,5x |
| Beam Therapeutics Inc. | BEAM | ██% | $3.09B | -x |
| Biogen Inc. | BIIB | ██% | $25.84B | 20,0x |
| Biontech Se | BNTX | ██% | $25.82B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $354M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $378M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $281M | -x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $9M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $630K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $888M | -x |
| Compugen Ltd | CGEN | ██% | $273M | 3,9x |
| Cg Oncology, Inc. | CGON | ██% | $5.35B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $99M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $285M | 1,7x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $3M | -x |
| Cellectis S.A. | CLLS | ██% | $440M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $1.16B | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $115M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $157M | -x |
| Curis Inc | CRIS | ██% | $24M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $5.34B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $85M | -x |
| Cel Sci Corp | CVM | ██% | $39M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $1.22B | -x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $463M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.23B | -x |
| Precision Biosciences Inc | DTIL | ██% | $181M | -x |
| Dyadic International Inc | DYAI | ██% | $32M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $328M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $420K | -x |
| Elutia Inc. | ELUT | ██% | $48M | 0,9x |
| Engene Therapeutics Inc. | ENGN | ██% | $541M | -x |
| Entera Bio Ltd. | ENTX | ██% | $65M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $71M | -x |
| Evaxion A/S | EVAX | ██% | $35M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.65B | 14,9x |
| Exozymes Inc. | EXOZ | ██% | $88M | -x |
| Fate Therapeutics Inc | FATE | ██% | $158M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $514M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $215M | -x |
| Finch Therapeutics Group, … | FNCH | ██% | $12M | 0,5x |
| Finch Therapeutics Group, … | FNCHQ | ██% | $12M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $173.45B | 20,4x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.47B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $17M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $47M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $8.02B | 25,3x |
| Humacyte, Inc. | HUMA | ██% | $154M | -x |
| Immunitybio, Inc. | IBRX | ██% | $7.87B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $236M | -x |
| Imagenebio, Inc. | IMA | ██% | $63M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.60B | -x |
| Immatics N.V. | IMTX | ██% | $1.47B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.58B | -x |
| In8bio, Inc. | INAB | ██% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $64M | -x |
| Inmune Bio, Inc. | INMB | ██% | $35M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $13M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.57B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $441M | -x |
| Invivyd, Inc. | IVVD | ██% | $482M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $29M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $134M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.59B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.84B | 38,3x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $7.24B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $568M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $396M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $300M | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $8M | -x |
| Leonabio, Inc. | LONA | ██% | $89M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $496M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.32B | -x |
| Mesoblast Ltd | MESO | ██% | $2.06B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $913M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $54M | -x |
| Molecular Partners Ag | MOLN | ██% | $170M | -x |
| Moderna, Inc. | MRNA | ██% | $21.38B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $13.16B | 27,5x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $359M | -x |
| Novavax Inc | NVAX | ██% | $1.41B | 3,2x |
| Ocugen, Inc. | OCGN | ██% | $609M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $29M | -x |
| Palisade Bio, Inc. | PALI | ██% | $392M | -x |
| Passage Bio, Inc. | PASG | ██% | $38M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $7.92B | -x |
| Biomx Inc. | PHGE | ██% | $13M | -x |
| Pluri Inc. | PLUR | ██% | $35M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $191M | -x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | -x |
| Prime Medicine, Inc. | PRME | ██% | $684M | -x |
| Prokidney Corp. | PROK | ██% | $605M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $74M | -x |
| Qiagen N.V. | QGEN | ██% | $9.03B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $20M | -x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $182M | -x |
| Repligen Corp | RGEN | ██% | $7.43B | 152,0x |
| Regenxbio Inc. | RGNX | ██% | $476M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $2.69B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $30.05B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.98B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $285M | 21,4x |
| Sana Biotechnology, Inc. | SANA | ██% | $918M | -x |
| Scilex Holding Co | SCLX | ██% | $44M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $122M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $805M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $29M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.39B | -x |
| Surrozen, Inc./De | SRZN | ██% | $366M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $496M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $276M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.96B | -x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $61M | -x |
| Bio-Techne Corp | TECH | ██% | $8.98B | 110,7x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $548M | -x |
| Instil Bio, Inc. | TIL | ██% | $58M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $163M | -x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.69B | -x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $26M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.48B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $412M | 45,8x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $539M | -x |
| Vericel Corp | VCEL | ██% | $1.73B | 104,6x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.65B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $729M | -x |
| Vaxart, Inc. | VXRT | ██% | $171M | 10,5x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $231M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $610K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $374M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $9M | -x |
| Zura Bio Ltd | ZURA | ██% | $520M | -x |
FAQ
-
Gilead Sciences, Inc. est-il une bonne action à acheter ?
Notre IA analyse Gilead Sciences, Inc. quotidiennement. Consultez le signal ci-dessus pour la dernière recommandation. Effectuez toujours vos propres recherches avant d'investir.
-
Quelle est la précision des prédictions de Gilead Sciences, Inc. ?
Notre IA atteint une corrélation de Spearman de 27% pour cette action, avec une précision moyenne supérieure à 67% sur plus de 4 000 actions analysées quotidiennement.
-
À quelle fréquence les prévisions sont-elles mises à jour ?
Les prévisions de Gilead Sciences, Inc. sont mises à jour quotidiennement avec les dernières données de marché et les modèles d'IA.
Prêt à investir plus intelligemment ?
Rejoignez des milliers d'investisseurs utilisant des prédictions boursières propulsées par l'IA
Inscription gratuite✓ Compte gratuit · ✓ Plus de 4 000 actions · ✓ Mises à jour quotidiennes
Vous cherchez une analyse plus approfondie de Gilead Sciences, Inc. ?
Voir l'analyse institutionnelle complète sur Intratio →Les prédictions IA sont basées sur des modèles historiques et ne doivent pas constituer la seule base pour les décisions d'investissement. Les performances passées ne garantissent pas les résultats futurs. Effectuez toujours vos propres recherches.